Astrotech Q1 net loss narrows on lower operating expenses
Overview
US mass spectrometry firm's fiscal Q1 revenue declined yr/yr
Net loss for fiscal Q1 narrowed compared to prior year
Operating expenses fell nearly 16% in fiscal Q1
Outlook
Company awaits NASA's decision on LEIA funding proposal, which could accelerate lunar initiatives
Result Drivers
OPERATING EXPENSES - Co attributed lower operating expenses in Q1 to reduced research and development costs
PRODUCT DEPLOYMENT - TRACER 1000 deployed in 38 locations across 17 countries, noted as operational progress
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue | $274,000 | ||
Q1 Loss Per Share | $1.46 | ||
Q1 Net Loss | $2.95 mln | ||
Q1 Gross Profit | $102,000 | ||
Q1 Operating Expenses | $3.14 mln |
Reuters Recommended Reads
Nov 12 - MultiSensor AI Q3 revenue dips on hardware and services decline
Nov 12 - Prime Medicine Q3 loss narrows as expenses decline
Nov 12 - Rocket Pharmaceuticals Q3 net loss narrows as R&D costs fall
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)